CDK2 and non-small cell lung carcinoma: Our results, the upregulation expression of HSP90AA1 and CDK2 was related to the inhibited action of NSCLC cells, confirmed the important role of the core targets in lung cancer and may provide new ideas for the related research on guiding the clinical treatment of lung cancer.